Cytosolix, Inc. — Form D
Cytosolix, Inc. of TOLLAND, CT, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-28. The offering totals $6.6M, of which $6.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-06-28
- Form: D
- Accession: 0001980943-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $6.6M
- Investors: 12
- Date of first sale: 2023-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-485381
Issuer
- Name: Cytosolix, Inc.
- CIK: 0001980943
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 97 ROBBIE ROAD, TOLLAND, CT, 06084
- Phone: (203) 606-5077
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Alex J Brunicki | Director | London, X0 |
| John J Deacon | Director | Tolland, CT |
| Colin J Foster | Director | Tolland, CT |
| Jason J Whitmire | Director | Berlin, 2M |
| John J Deacon | Executive Officer | Tolland, CT |
| Colin J Foster | Executive Officer | Tolland, CT |
More